ABO gene polymorphism and COVID-19 severity: The impact on haematological complications, inflammatory markers, and lung lesions.

MLA

Samet, Mohammad, et al. “ABO Gene Polymorphism and COVID-19 Severity: The Impact on Haematological Complications, Inflammatory Markers, and Lung Lesions.” Human Immunology, vol. 85, no. 6, Nov. 2024, p. 111184. EBSCOhost, https://doi.org/10.1016/j.humimm.2024.111184.

APA

Samet, M., Mahdiabadi, P. R., Tajamolian, M., Jelodar, M. G., Monshizadeh, K., Javazm, R. R., Yazdi, M., Abessi, P., & Hoseini, S. M. (2024). ABO gene polymorphism and COVID-19 severity: The impact on haematological complications, inflammatory markers, and lung lesions. Human Immunology, 85(6), 111184. https://doi.org/10.1016/j.humimm.2024.111184

Chicago

Samet, Mohammad, Parvane Raeesi Mahdiabadi, Masoud Tajamolian, Mohsen Gholinataj Jelodar, Kimia Monshizadeh, Reza Rafiei Javazm, Mehran Yazdi, Panteha Abessi, and Seyed Mehdi Hoseini. 2024. “ABO Gene Polymorphism and COVID-19 Severity: The Impact on Haematological Complications, Inflammatory Markers, and Lung Lesions.” Human Immunology 85 (6): 111184. doi:10.1016/j.humimm.2024.111184.